Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Blog
Biosimilars Council Press Releases
Blog
Blog
October 27, 2021
AAM
AAM All Access Podcast: Celebrating Pharmacists
Blog
October 26, 2021
AAM
Inflation-Based Rebates Need Not Apply
Blog
October 18, 2021
AAM
Five Breast Cancer Facts
Blog
October 18, 2021
AAM
AAM All Access Podcast: Lupin’s Vinita Gupta
Blog
October 16, 2021
AAM
AAM All Access Podcast: Apotex’s Jeff Watson
Blog
October 8, 2021
AAM
AAM All Access Podcast: Golden State Medical Supply’s Anthony Principi
Blog
October 1, 2021
AAM
Celebrating One Year as AAM CEO
Blog
September 30, 2021
AAM
A Commitment to Membership Enhances AAM’s Mission
Blog
September 21, 2021
Founders Series
Thank you, Kanu Patel
Blog
September 2, 2021
AAM
Member Spotlight: Zydus USA
Blog
August 27, 2021
AAM
Our Team
Blog
July 19, 2021
AAM
Seniors Are Still Missing Out on Savings in Medicare Part D
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH